Abc Pharma S.R.O. (Czech Republic)

Main Activities: Wholesale Trade | Retail Trade | Office Administrative Services

Secondary Activities: All Other Support Activities for Transportation | Lessors of Other Real Estate Property | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Professional, Scientific, and Technical Services

Full name: Abc Pharma S.R.O.

Profile Updated: December 08, 2025

Abc Pharma S.R.O. is an enterprise based in Czech Republic. Its main office is in Bohumin. It operates in the Wholesale Trade sector. The company was established on November 14, 2019. Abc Pharma S.R.O. currently employs 6 - 9 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 76.75% in 2024. Its’ total assets recorded a growth of 2.18%. Abc Pharma S.R.O.’s net profit margin decreased by 2.1% in 2024.

Headquarters
Cs. armady 360
Bohumin; Moravskoslezsky; Postal Code: 73551

Contact Details: Purchase the Abc Pharma S.R.O. report to view the information.

Basic Information

Total Employees:

Purchase the Abc Pharma S.R.O. report to view the information.

Registered Capital:

Purchase the Abc Pharma S.R.O. report to view the information.

Financial Auditors:

Purchase the Abc Pharma S.R.O. report to view the information.

Incorporation Date:

November 14, 2019

Key Executives

Purchase this report to view the information.

Legal Representative

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Abc Pharma S.R.O. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.

Net sales revenue

76.75%▲

Total operating revenue

88.47%▲

Operating profit (EBIT)

-13.16%▼

EBITDA

-9.54%▼

Net Profit (Loss) for the Period

-11.72%▼

Total Assets

2.18%▲

Total Equity

31.52%▲

Operating Profit Margin (ROS)

-2.69%▼

Net Profit Margin

-2.1%▼

Return on Equity (ROE)

-11.74%▼

Quick Ratio

0.36%▲

Cash Ratio

0.09%▲

Similar companies

Related EMIS Industry Reports